Alzheimer's Clinical Trials Consortium

• The Progressive Supranuclear Palsy Clinical Trial Platform

  Collaborator, Phase 2, Recruiting, 440 people, 15 Sept 2025

• NCT07167966

  Collaborator, Phase 2, Enrolling by invitation, 450 people, 11 Sept 2025

• NCT06911944

  Collaborator, Phase 4, Not yet recruiting, 60 people, 4 Apr 2025

• AHEAD 3-45 Study: A Study to Evaluate Efficacy and Safety of Treatment With Lecanemab in Participants With Preclinical Alzheimer's Disease and Elevated Amyloid and Also in Participants With Early Preclinical Alzheimer's Disease and Intermediate Amyloid

  Collaborator, Phase 3, Active, not recruiting, 1,400 people, 13 Jul 2020

Sources: clinicaltrials.gov

• Plasma Phosphorylated Tau 217 Percentage by Race and Ethnicity in Preclinical Alzheimer Disease

  Fees or honoraria, Grants or research support, 12 Oct 2026

• Relationship Between SSRI Exposure During Later Life and Clinical and Neuropathological Correlates of Dementia

  Grants or research support, 25 Sept 2025

Sources: pubmed.ncbi.nlm.nih.gov